Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.
Hualan Biological Engineering Dividend Announcement
• Hualan Biological Engineering announced a annually dividend of ¥0.30 per ordinary share which will be made payable on 2024-06-14. Ex dividend date: 2024-06-14
• Hualan Biological Engineering annual dividend for 2024 was ¥0.30
• Hualan Biological Engineering annual dividend for 2023 was ¥0.30
• Hualan Biological Engineering's trailing twelve-month (TTM) dividend yield is 1.79%
• Hualan Biological Engineering's payout ratio for the trailing twelve months (TTM) is 76.03%
• Hualan Biological Engineering's dividend growth over the last ten years (2013-2023) was 11.61% year
Hualan Biological Engineering Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-14 | ¥0.30 | annually | 2024-06-14 |
2023-06-14 | ¥0.30 | annually | 2023-06-14 |
2022-06-16 | ¥0.20 | annually | 2022-06-16 |
2021-06-23 | ¥0.30 | annually | 2021-06-23 |
2020-04-27 | ¥0.40 | annually | 2020-04-27 |
2019-06-17 | ¥0.40 | annually | 2019-06-17 |
2018-06-27 | ¥0.30 | annually | 2018-06-27 |
2017-06-13 | ¥0.40 | annually | 2017-06-13 |
2016-06-07 | ¥0.40 | annually | |
2015-06-05 | ¥0.60 | annually | |
2014-06-20 | ¥0.40 | annually | |
2013-06-24 | ¥0.10 | annually |
Hualan Biological Engineering Dividend per year
Hualan Biological Engineering Dividend growth
Hualan Biological Engineering Dividend Yield
Hualan Biological Engineering current trailing twelve-month (TTM) dividend yield is 1.79%. Interested in purchasing Hualan Biological Engineering stock? Use our calculator to estimate your expected dividend yield:
Hualan Biological Engineering Financial Ratios
Hualan Biological Engineering Dividend FAQ
Other factors to consider when evaluating Hualan Biological Engineering as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Hualan Biological Engineering stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Hualan Biological Engineering's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Hualan Biological Engineering publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Hualan Biological Engineering distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Hualan Biological Engineering are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Hualan Biological Engineering sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Hualan Biological Engineering distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Hualan Biological Engineering declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Hualan Biological Engineering's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Hualan Biological Engineering's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.